Oncological reasons for performing a complete mesocolic excision: a systematic review and meta-analysis

Simple item page
dc.contributor.authorKong J.C.
dc.contributor.authorLarach J.T.
dc.contributor.authorHeriot A.
dc.contributor.authorWarrier S.K.
dc.contributor.authorKong J.C.
dc.contributor.authorHeriot A.
dc.contributor.authorWarrier S.K.
dc.contributor.authorKong J.C.
dc.contributor.authorHeriot A.
dc.contributor.authorWarrier S.K.
dc.contributor.authorPrabhakaran S.
dc.contributor.authorChoy K.T.
dc.contributor.authorLarach J.T.
dc.date.accessioned2025-05-01T10:30:16Z
dc.date.available2025-05-01T10:30:16Z
dc.date.issued2021
dc.description.abstract© 2021 Royal Australasian College of SurgeonsBackground: While complete mesocolic excision (CME) has been shown to have an oncological benefit as compared to conventional colonic surgery for colon surgery, this benefit must be weighed up against the risk of major intra-abdominal complications. This paper aimed to assess the comparative oncological benefits of CME. Methods: Following the Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines, a systematic review of the literature until May 2020 was performed. Comparative studies assessing CME versus conventional colonic surgery for colon cancer were compared, and outcomes were pooled. Results: A total of 700 publications were identified, of which 19 were found to meet the inclusion criteria. A total of 25 886 patients were compared, with 14 431 patients in the CME arm. CME was associated with a significantly higher rate of vascular injury (odds ratio 3, P < 0.001). Rates of local and distant recurrence were lower in the CME group (odds ratio 0.66 and 0.73, respectively, both P < 0.001). CME patients had a significantly higher lymph node yield (P < 0.001). While no significant differences were noted between the two groups in terms of pooled 3- or 5-year disease-free survival, pooled 5-year overall survival was significantly higher in the CME group (relative risk 0.82, P < 0.001). Conclusion: Based on the available evidence, CME is associated with improved oncologic outcomes at the expense of higher complication rates, including vascular injury. The oncological benefits need to weighed up against a multitude of factors including the level of hospital support, surgeon experience, patient age, and associated comorbidities.
dc.description.funderANID
dc.description.funderSergio San Mart?n
dc.description.funderFONDECYT
dc.format.extent10 páginas
dc.fuente.origenScopus
dc.identifier.doi10.1111/ans.16518
dc.identifier.eissn14452197
dc.identifier.issn14452197 14451433
dc.identifier.pubmedid33400369
dc.identifier.scieloidS0716-27902024000100135
dc.identifier.scopusidSCOPUS_ID:85099046559
dc.identifier.urihttps://doi.org/10.1111/ans.16518
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/103610
dc.identifier.wosidWOS:000604733400001
dc.information.autorucEscuela de Medicina; Larach Kattan Jose Tomas; 0000-0001-5242-9456; 131898
dc.information.autorucEscuela de Medicina; Larach Kattan Jose Tomas; 0000-0001-5242-9456; 131898
dc.issue.numeroCD011973
dc.language.isoen
dc.nota.accesoSin adjunto
dc.pagina.final131
dc.pagina.inicio124
dc.relation.ispartof16th International Vasculitis & ANCA Workshop
dc.revistaANZ Journal of Surgery
dc.rightsAcceso cerrado
dc.subjectcolorectal cancer
dc.subjectcomplete mesocolic excision
dc.subjectcomplete mesocolic rection
dc.subjectD3 resection
dc.subject.ddc610
dc.subject.deweyMedicina y saludes_ES
dc.titleOncological reasons for performing a complete mesocolic excision: a systematic review and meta-analysis
dc.typeartículo
dc.volumen91
sipa.codpersvinculados131898
sipa.codpersvinculados131898
sipa.indexScopus
sipa.indexPubmed
sipa.trazabilidadCarga WOS-SCOPUS;01-05-2025
Files
Collections
Artículos de revistas